MIR
Mirion Technologies, Inc. NYSE$20.16
Mkt Cap $4.9B
52w Low $15.55
31.3% of range
52w High $30.28
50d MA $19.78
200d MA $22.77
P/E (TTM)
151.0x
EV/EBITDA
29.3x
P/B
2.4x
Debt/Equity
0.7x
ROE
1.4%
P/FCF
50.4x
RSI (14)
—
ATR (14)
—
Beta
1.09
50d MA
$19.78
200d MA
$22.77
Avg Volume
3.8M
About
Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, and Japan. It operates through two segments, Medical and Industrial. The medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safe…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | AMC | 0.10 | 0.10 | +0.0% | 18.68 | -2.0% | -0.1% | +5.7% | +5.1% | +7.9% | +7.2% | — |
| Feb 10, 2026 | AMC | 0.16 | 0.15 | -6.2% | 23.44 | +3.7% | -10.2% | -8.4% | -4.0% | -6.2% | -8.5% | — |
| Oct 28, 2025 | AMC | 0.11 | 0.12 | +9.1% | 25.19 | -0.1% | +18.1% | +15.2% | +16.6% | +16.8% | +10.4% | — |
| Jul 31, 2025 | AMC | 0.10 | 0.11 | +10.0% | 22.35 | -10.2% | -11.1% | -6.9% | -3.8% | -3.6% | -3.9% | — |
| Apr 29, 2025 | AMC | 0.10 | 0.10 | +0.0% | 15.62 | -2.2% | +1.0% | +0.8% | +3.8% | +2.1% | +3.4% | — |
| Feb 11, 2025 | AMC | 0.14 | 0.17 | +21.4% | 16.17 | +3.4% | +1.2% | +0.5% | +0.8% | +1.2% | +4.7% | — |
| Oct 29, 2024 | AMC | 0.11 | 0.08 | -27.3% | 14.07 | -8.5% | +4.8% | +5.2% | +4.1% | +5.1% | +6.6% | — |
| Aug 1, 2024 | AMC | 0.08 | 0.10 | +25.0% | 10.30 | +0.4% | -2.0% | -6.1% | -4.9% | -5.0% | -1.8% | — |
| Apr 30, 2024 | AMC | 0.06 | 0.06 | +0.0% | 10.87 | -2.9% | -6.2% | -8.6% | -8.2% | -7.5% | -7.0% | — |
| Feb 13, 2024 | AMC | 0.14 | 0.15 | +7.1% | 9.42 | +8.6% | +6.7% | +6.4% | +6.3% | +4.8% | +3.8% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 | Citigroup | Maintains | Buy → Buy | — | $18.66 | $18.79 | +0.7% | +5.8% | +5.2% | — | — | — |
| Mar 30 | Baird | Maintains | Outperform → Outperform | — | $17.89 | $17.97 | +0.4% | -3.2% | +3.9% | +4.3% | +6.2% | +5.9% |
| Mar 26 | JP Morgan | Maintains | Overweight → Overweight | — | $18.81 | $18.41 | -2.1% | -3.0% | -4.9% | -7.9% | -1.2% | -0.8% |
| Mar 11 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $21.36 | $21.22 | -0.7% | +1.2% | -6.2% | -12.5% | -13.2% | -9.8% |
| Mar 9 | JP Morgan | Maintains | Overweight → Overweight | — | $20.54 | $19.99 | -2.7% | +4.3% | +4.0% | +5.2% | -2.4% | -9.0% |
| Feb 12 | Goldman Sachs | Maintains | Buy → Buy | — | $21.05 | $21.26 | +1.0% | +2.0% | +6.9% | +4.5% | +1.9% | +2.0% |
| Feb 12 | Citigroup | Maintains | Buy → Buy | — | $21.05 | $21.26 | +1.0% | +2.0% | +6.9% | +4.5% | +1.9% | +2.0% |
| Dec 8 | Citigroup | Maintains | Buy → Buy | — | $25.02 | $25.62 | +2.4% | +1.1% | +0.7% | +0.8% | +5.1% | -1.4% |
| Oct 31 | Citigroup | Maintains | Buy → Buy | — | $29.03 | $29.37 | +1.2% | +1.2% | +1.3% | -4.2% | -1.7% | -5.1% |
| Oct 30 | JP Morgan | Maintains | Overweight → Overweight | — | $29.75 | $29.70 | -0.2% | -2.4% | -1.3% | -1.1% | -6.5% | -4.0% |
Recent Filings
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
MIR's grant of stock options to an executive creates upside-only incentives tied to stock appreciation beyond baseline performance expectations, potentially aligning leadership interests with shareholder returns if the company outperforms.
Apr 13
8-K
Mirion Technologies, Inc. -- 8-K Filing
Mirion Technologies reported Q4 2025 revenues of $277.4 million, up 9.1% year-over-year, with GAAP net income rising 11.9% to $17.8 million, demonstrating accelerating profitability growth.
Feb 10
Data updated apr 26, 2026 12:20pm
· Source: massive.com